- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ginkgo Bioworks Holdings (DNA)
Ginkgo Bioworks Holdings stock price live, this page displays NYSE DNA stock exchange data. View the DNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ginkgo Bioworks Holdings real time stock price chart below.
What Is the Ginkgo Bioworks Holdings Stock Price Today?
The Ginkgo Bioworks Holdings stock price today is 7.970.
What Is the Stock Symbol for Ginkgo Bioworks Holdings?
The stock symbol for Ginkgo Bioworks Holdings is "DNA."
What Stock Exchange Does Ginkgo Bioworks Holdings Trade On?
Ginkgo Bioworks Holdings is listed and trades on the NYSE stock exchange.
Is Ginkgo Bioworks Holdings a Good Stock to Buy?
Determining whether Ginkgo Bioworks Holdings—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DNA quote. (ISIN: US37611X2099)
What Is the Ginkgo Bioworks Holdings Stock Price Today?
The Ginkgo Bioworks Holdings stock price today is 7.970.
What Is the Stock Symbol for Ginkgo Bioworks Holdings?
The stock symbol for Ginkgo Bioworks Holdings is "DNA."
What Stock Exchange Does Ginkgo Bioworks Holdings Trade On?
Ginkgo Bioworks Holdings is listed and trades on the NYSE stock exchange.
Is Ginkgo Bioworks Holdings a Good Stock to Buy?
Determining whether Ginkgo Bioworks Holdings—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DNA quote. (ISIN: US37611X2099)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.490
8.370
52 wk Range
5.370
17.580
DNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.4908.370
52 wk Range
5.37017.580
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DNA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
7.000
Downside
-12.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
ProQR prices $50M stock offering at $1.81 per share- Investing.com
Form 4 Ginkgo Bioworks Holdings For: 15 June- Investing.com
Form 144 Ginkgo Bioworks Holdings For: 17 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
1 Hold
2 Sell
Ratings:
3 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 7.000
(-12.17% Downside)
Ginkgo Bioworks Holdings Earnings Call Summary for Q2/2026
- Q2 revenue fell 48% YoY to $20M, missing $29.9M consensus by 33%; adjusted EPS of -$0.92 beat estimates of -$1.05, but shares dropped 4.89% after-hours.
- Company reaffirmed FY2026 cash burn guidance of $125M-$150M; ended quarter with $389M total liquidity including restricted cash and $302M in cash equivalents.
- Ginkgo refocused strategy on autonomous laboratory technology after divesting biosecurity business in April, now operating as single segment with expanded Nebula system.
- Management declined to provide revenue guidance or segment breakdowns; plans to expand autonomous lab sales to biopharma, national labs, and universities while adding chemistry automation.
- CEO Kelly emphasized autonomous labs as competitive response to China in biotech; Q2 cash burn rose 18% to $45M while G&A expenses fell 26% from restructuring actions.
Last Updated: 2026-08-05, 07:04 p/m
Read Full TranscriptEarnings
Latest Release
Aug 05, 2026
EPS / Forecast
-0.92 / -1.05
Revenue / Forecast
20M / 29.9M
Compare DNA to Peers and Sector
Metrics to compare | DNA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDNAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.7x | −7.6x | −0.4x | |
PEG Ratio | −0.11 | −0.27 | 0.00 | |
Price/Book | 1.3x | 2.0x | 2.6x | |
Price / LTM Sales | 4.1x | 9.8x | 3.0x | |
Upside (Analyst Target) | −12.2% | 53.3% | 48.7% | |
Fair Value Upside | Unlock | −15.1% | 5.6% | Unlock |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ginkgo Bioworks (DNA) Stock Price Today?
The Ginkgo Bioworks stock price today is 7.970 USD.
What Stock Exchange Does Ginkgo Bioworks Trade On?
Ginkgo Bioworks is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Ginkgo Bioworks?
The stock symbol for Ginkgo Bioworks is "DNA."
What Is the Ginkgo Bioworks Market Cap?
As of today, Ginkgo Bioworks market cap is 555.260M USD.
What Is Ginkgo Bioworks's Earnings Per Share (TTM)?
The Ginkgo Bioworks EPS (TTM) is -4.960.
When Is the Next Ginkgo Bioworks Earnings Date?
Ginkgo Bioworks will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is DNA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ginkgo Bioworks Stock Split?
Ginkgo Bioworks has split 1 times.
How Many Employees Does Ginkgo Bioworks Have?
Ginkgo Bioworks has 485 employees.
What is the current trading status of Ginkgo Bioworks (DNA)?
As of Aug 08, 2026, Ginkgo Bioworks (DNA) is trading at a price of 7.970 USD, with a previous close of 8.500 USD. The stock has fluctuated within a day range of 7.490 USD to 8.370 USD, while its 52-week range spans from 5.370 USD to 17.580 USD.
What Is Ginkgo Bioworks (DNA) Price Target According to Analysts?
The average 12-month price target for Ginkgo Bioworks is 7.000 USD, with a high estimate of 9 USD and a low estimate of 5 USD. 0 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Sell. The stock has an -12.17% Downside potential.
What Is the DNA Premarket Price?
DNA's last pre-market stock price is 8.330 USD. The pre-market share volume is 5,350.000, and the stock has decreased by -0.170, or -2.000%.
What Is the DNA After Hours Price?
DNA's last after hours stock price is 7.900 USD, the stock has decreased by -0.070, or -0.880%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.